The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary ...
Robert is currently chief digital officer at the cruise line firm Viking Cruises and will join Sanofi on 15th June. His brief is to drive Sanofi’s digital, data and technology strategy ...
Sanofi said this morning that its pipeline includes ... build-up to an R&D presentation to investors that will be held in New York later today, and also after the France-headquartered group ...
Hosted on MSN14d
Sanofi CEO believes company poised for growth from new drugsNEW YORK (Reuters) -Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent ...
David Banks and Philip Banks III eclipsed their younger brother by rising to help run New York City. Then federal prosecutors seized the phones of all three men. By Joseph GoldsteinEliza Shapiro ...
Bank of New York Mellon ... a new stake in Sanofi in the fourth quarter valued at approximately $28,000. Larson Financial Group LLC boosted its stake in shares of Sanofi by 480.8% during the ...
I am currently accepting new clients for both individual ... from Cambridge College, Boston, MA and a Bachelor’s Degree in Psychology from Framingham State University. I have been working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback